Waters Corp

NYSE:WATUnited States

Apr 22, 2024

Show headlines and story abstract

• --Bernstein Adjusts Price Target on Waters to $304 From $307, from 9:20AM ET on Monday Apr 22, 2024 by MT Newswires

  9:20AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: WAT
  09:20 AM EDT, 04/22/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...

• --Baird Adjusts Price Target on Waters to $319 From $315, from 8:50AM ET on Monday Apr 22, 2024 by MT Newswires

  8:50AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: WAT
  08:50 AM EDT, 04/22/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...

• Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns, from 8:01AM ET on Monday Apr 22, 2024 by PR Newswire

  8:01AM ET on Monday Apr 22, 2024 by PR Newswire
  Companies Mentioned: WAT

  News Summary:

  -- New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics.

  -- Reduces problematic non-specific binding, minimizes mobile phase method development challenges, and provides higher throughput separation efficiency.

• Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns, from 8:00AM ET on Monday Apr 22, 2024 by Dow Jones

  8:00AM ET on Monday Apr 22, 2024 by Dow Jones
  Companies Mentioned: WAT
  
  Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
  
  PR Newswire
  
  MILFORD, Mass., April 22, 2024
  
  News Summary: